Evaluation of Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Patients With/Without Substitution Therapy in Austria.
Phase of Trial: Phase IV
Latest Information Update: 14 Nov 2013
At a glance
- Drugs Buprenorphine; Methadone; Morphine; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 22 Apr 2012 Actual patient number changed from 333 to 353 as reported by ClinicalTrials.gov.
- 15 Apr 2011 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.
- 28 Jan 2011 Planned end date changed from Nov 2010 to Mar 2011 as reported by ClinicalTrials.gov.